ReviewOncoTargets and therapy2019

Update on elotuzumab for the treatment of relapsed/refractory multiple myeloma: patients' selection and perspective.

Sabrina Trudel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.